X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/drug-delivery/nucanas-twist-chemo-drug-gemzar-fails-phase-3-again
https://www.globenewswire.com/news-release/2022/02/22/2389768/0/en/NuCana-Announces-Enrollment-of-Required-Number-of-Patients-to-Conduct-Second-Interim-Analysis-in-the-Phase-III-Biliary-Tract-Cancer-Study.html
https://www.globenewswire.com/news-release/2021/08/19/2283856/0/en/NuCana-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/fr/news-release/2021/01/15/2159352/0/en/NuCana-Presents-Encouraging-Data-at-ASCO-GI-for-NUC-3373-in-Heavily-Pre-Treated-Patients-with-Metastatic-Colorectal-Cancer.html
https://www.globenewswire.com/news-release/2020/05/05/2027874/0/en/NuCana-Announces-Re-Opening-of-Global-Phase-III-Study-of-Acelarin-Plus-Cisplatin-in-Patients-with-Biliary-Tract-Cancer-NuTide-121.html
https://www.globenewswire.com/fr/news-release/2020/03/10/1998330/0/en/NuCana-Reports-Preliminary-Data-from-Phase-II-Study-of-Single-Agent-Acelarin-NUC-1031-in-Patients-with-Platinum-Resistant-Ovarian-Cancer.html
https://www.biospace.com/article/-nucana-receives-positive-opinion-for-orphan-drug-designation-in-the-european-union-for-acelarin-nuc-1031-for-the-treatment-of-patients-with-biliary-tract-cancer/
Market Place
Share 
